(Q37794781)

23 August 2017

title

Progress and prospects: stem cells and neurological diseases (English)

1 reference

23 August 2017

S Gögel

1

1 reference

23 August 2017

M Gubernator

series ordinal

2

1 reference

23 August 2017

S L Minger

series ordinal

3

1 reference

23 August 2017

publication date

30 September 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

18

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

1-6

1 reference

https://scigraph.springernature.com/pub.10.1038/gt.2010.130

23 August 2017

exact match

0 references

cites work

Cell replacement therapy for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

Human stem cells for CNS repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Stem cell-based cell therapy in neurological diseases: a review

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

The regulation of human embryo and stem-cell research in the United Kingdom.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Cell-based interventions for neurologic conditions: ethical challenges for early human trials

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Gene expression changes in long term expanded human neural progenitor cells passaged by chopping lead to loss of neurogenic potential in vivo

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Induced pluripotent stem cell lines derived from human somatic cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Stem cell transplantation for Huntington's disease.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Alloimmunisation to donor antigens and immune rejection following foetal neural grafts to the brain in patients with Huntington's disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Neural transplantation in Huntington disease: long-term grafts in two patients

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

A patient with Huntington's disease and long-surviving fetal neural transplants that developed mass lesions

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Long-term clinical and positron emission tomography outcome of fetal striatal transplantation in Huntington's disease.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Histological findings on fetal striatal grafts in a Huntington's disease patient early after transplantation

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Endogenous neurogenesis in the human brain following cerebral infarction

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Increased neural progenitors in vascular dementia

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Human neural stem cells overexpressing glial cell line-derived neurotrophic factor in experimental cerebral hemorrhage

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Human neural stem cells over-expressing VEGF provide neuroprotection, angiogenesis and functional recovery in mouse stroke model

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility study

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Autologous mesenchymal stem cell transplantation in stroke patients

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Potential of adult neural stem cells in stroke therapy

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Optimizing the success of cell transplantation therapy for stroke

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Stem cell therapy in stroke.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Endothelial cells support survival, proliferation, and neuronal differentiation of transplanted adult ischemia-induced neural stem/progenitor cells after cerebral infarction

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Endothelial progenitor cell transplantation improves long-term stroke outcome in mice.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Gene and stem cell therapy in ischemic stroke

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Neuroprotective effect of grafting GDNF gene-modified neural stem cells on cerebral ischemia in rats

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Treatment of Parkinson disease with C17.2 neural stem cells overexpressing NURR1 with a recombined republic-deficit adenovirus containing the NURR1 gene

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Cell-replacement and gene-therapy strategies for Parkinson's and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Emerging restorative treatments for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Combined use of BDNF, ascorbic acid, low oxygen, and prolonged differentiation time generates tyrosine hydroxylase-expressing neurons after long-term in vitro expansion of human fetal midbrain precursor cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Enhanced yield of neuroepithelial precursors and midbrain-like dopaminergic neurons from human embryonic stem cells using the bone morphogenic protein antagonist noggin.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Efficient production of mesencephalic dopamine neurons by Lmx1a expression in embryonic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Cooperative transcription activation by Nurr1 and Pitx3 induces embryonic stem cell maturation to the midbrain dopamine neuron phenotype.

1 reference

https://api.crossref.org/works/10.1038%2FGT.2010.130

7 January 2021

Identifiers

DOI

10.1038/GT.2010.130

1 reference

23 August 2017

1 reference